Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 175

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Streptococcus pneumoniae: Invasion and Inflammation

Open access
Loughran, Allister J., Orihuela, Carlos J., Tuomanen, Elaine I. · 2019 · Microbiology Spectrum

Abstract

Streptococcus pneumoniae (the pneumoccus) is the leading cause of otitis media, community-acquired pneumonia, and bacterial meningitis. The success of the pneumococcus stems from its ability to persist in the population as a commensal and avoid killing by immune system. This chapter first reviews the molecular mechanisms that allow the pneumococcus to colonize and spread from one anatomical site to the next. Then, it discusses the mechanisms of inflammation and cytotoxicity during emerging and classical pneumococcal infections.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/microbiolspec.gpp3-0004-2018

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 180

  1. Austrian R. 1986. Some aspects of the pneumococcal carrier state. J Antimicrob Chemother 18 (Suppl A) : 35–45. [PubMed] · DOI · Paper page
  2. Marks LR Reddinger RM Hakansson AP. 2014. Biofilm formation enhances fomite survival of Streptococcus pneumoniae and Streptococcus pyogenes . Infect Immun 82: 1141–1146 http://dx.doi.org/10.1128/IAI.01310-13.[PubMed] · DOI
  3. Musher DM. 2003. How contagious are common respiratory tract infections? N Engl J Med 348: 1256–1266 http://dx.doi.org/10.1056/NEJMra021771. [PubMed] · DOI · Paper page
  4. Melegaro A Gay NJ Medley GF. 2004. Estimating the transmission parameters of pneumococcal carriage in households. Epidemiol Infect 132: 433–441 http://dx.doi.org/10.1017/S0950268804001980. [PubMed] · doi:10.1017/s0950268804001980
  5. Regev-Yochay G Raz M Dagan R Porat N Shainberg B Pinco E Keller N Rubinstein E. 2004. Nasopharyngeal carriage of Streptococcus pneumoniae by adults and children in community and family settings. Clin Infect Dis 38: 632–639 http://dx.doi.org/10.1086/381547. [PubMed] · DOI · Paper page
  6. Wyllie AL Rümke LW Arp K Bosch AA Bruin JP Rots NY Wijmenga-Monsuur AJ Sanders EA Trzciński K. 2016. Molecular surveillance on Streptococcus pneumoniae carriage in non-elderly adults; little evidence for pneumococcal circulation independent from the reservoir in children. Sci Rep 6: 34888 http://dx.doi.org/10.1038/srep34888. [PubMed] · DOI
  7. Wyllie AL Wijmenga-Monsuur AJ van Houten MA Bosch AA Groot JA van Engelsdorp Gastelaars J Bruin JP Bogaert D Rots NY Sanders EA Trzciński K. 2016. Molecular surveillance of nasopharyngeal carriage of Streptococcus pneumoniae in children vaccinated with conjugated polysaccharide pneumococcal vaccines. Sci Rep 6: 23809 http://dx.doi.org/10.1038/srep23809. [PubMed] · DOI
  8. Davidson M Parkinson AJ Bulkow LR Fitzgerald MA Peters HV Parks DJ. 1994. The epidemiology of invasive pneumococcal disease in Alaska 1986-1990: ethnic differences and opportunities for prevention. J Infect Dis 170: 368–376 http://dx.doi.org/10.1093/infdis/170.2.368. [PubMed] · DOI · Paper page
  9. Torzillo PJ Hanna JN Morey F Gratten M Dixon J Erlich J. 1995. Invasive pneumococcal disease in central Australia. Med J Aust 162: 182–186. [PubMed] · DOI
  10. Morris PS Leach AJ Silberberg P Mellon G Wilson C Hamilton E Beissbarth J. 2005. Otitis media in young Aboriginal children from remote communities in Northern and Central Australia: a cross-sectional survey. BMC Pediatr 5: 27 http://dx.doi.org/10.1186/1471-2431-5-27. [PubMed] · DOI · Paper page
  11. Mackenzie GA Leach AJ Carapetis JR Fisher J Morris PS. 2010. Epidemiology of nasopharyngeal carriage of respiratory bacterial pathogens in children and adults: cross-sectional surveys in a population with high rates of pneumococcal disease. BMC Infect Dis 10: 304 http://dx.doi.org/10.1186/1471-2334-10-304. [PubMed] · DOI · Paper page
  12. Smith-Vaughan H Marsh R Mackenzie G Fisher J Morris PS Hare K McCallum G Binks M Murphy D Lum G Cook H Krause V Jacups S Leach AJ. 2009. Age-specific cluster of cases of serotype 1 Streptococcus pneumoniae carriage in remote indigenous communities in Australia. Clin Vaccine Immunol 16: 218–221 http://dx.doi.org/10.1128/CVI.00283-08. [PubMed] · doi:10.1128/cvi.00283-08
  13. Gray BM Turner ME Dillon HC Jr. 1982. Epidemiologic studies of Streptococcus pneumoniae in infants. The effects of season and age on pneumococcal acquisition and carriage in the first 24 months of life. Am J Epidemiol 116: 692–703 http://dx.doi.org/10.1093/oxfordjournals.aje.a113452. [PubMed] · DOI
  14. Gray BM Converse GM III Dillon HC Jr. 1980. Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition carriage and infection during the first 24 months of life. J Infect Dis 142: 923–933 http://dx.doi.org/10.1093/infdis/142.6.923. [PubMed] · DOI · Paper page
  15. Dunais B Pradier C Carsenti H Sabah M Mancini G Fontas E Dellamonica P. 2003. Influence of child care on nasopharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae . Pediatr Infect Dis J 22: 589–592 http://dx.doi.org/10.1097/01.inf.0000073203.88387.eb. [PubMed] · DOI
  16. Smith T Lehmann D Montgomery J Gratten M Riley ID Alpers MP. 1993. Acquisition and invasiveness of different serotypes of Streptococcus pneumoniae in young children. Epidemiol Infect 111: 27–39 http://dx.doi.org/10.1017/S0950268800056648. [PubMed] · doi:10.1017/s0950268800056648
  17. Högberg L Geli P Ringberg H Melander E Lipsitch M Ekdahl K. 2007. Age- and serogroup-related differences in observed durations of nasopharyngeal carriage of penicillin-resistant pneumococci. J Clin Microbiol 45: 948–952 http://dx.doi.org/10.1128/JCM.01913-06. [PubMed] · DOI
  18. Davis SM Deloria-Knoll M Kassa HT O’Brien KL. 2013. Impact of pneumococcal conjugate vaccines on nasopharyngeal carriage and invasive disease among unvaccinated people: review of evidence on indirect effects. Vaccine 32: 133–145 http://dx.doi.org/10.1016/j.vaccine.2013.05.005. [PubMed] · DOI · Paper page
  19. Nunes S Sá-Leão R Carriço J Alves CR Mato R Avô AB Saldanha J Almeida JS Sanches IS de Lencastre H. 2005. Trends in drug resistance serotypes and molecular types of Streptococcus pneumoniae colonizing preschool-age children attending day care centers in Lisbon Portugal: a summary of 4 years of annual surveillance. J Clin Microbiol 43: 1285–1293 http://dx.doi.org/10.1128/JCM.43.3.1285-1293.2005. [PubMed] · DOI
  20. Butler JC. 2004. Epidemiology of pneumococcal disease p 148–168. In Tuomanen EI Mitchell TJ Morrison DA Spratt BG (ed) The Pneumococcus . ASM Press Washington DC. · DOI
  21. Grau I Ardanuy C Calatayud L Rolo D Domenech A Liñares J Pallares R. 2012. Invasive pneumococcal disease in healthy adults: increase of empyema associated with the clonal-type Sweden(1)-ST306. PLoS One 7: e42595 http://dx.doi.org/10.1371/journal.pone.0042595. [PubMed] · DOI
  22. Lehmann D Willis J Moore HC Giele C Murphy D Keil AD Harrison C Bayley K Watson M Richmond P. 2010. The changing epidemiology of invasive pneumococcal disease in aboriginal and non-aboriginal western Australians from 1997 through 2007 and emergence of nonvaccine serotypes. Clin Infect Dis 50: 1477–1486 http://dx.doi.org/10.1086/652440. [PubMed] · doi:10.1086/652440
  23. Fedson DS Musher DM Eskola J. 1998. Pneumococcal vaccine. In Plotkin SA Ordenstein WA (ed) Vaccines 3rd ed. WB Saunders Philadelphia PA.
  24. Huang SS Johnson KM Ray GT Wroe P Lieu TA Moore MR Zell ER Linder JA Grijalva CG Metlay JP Finkelstein JA. 2011. Healthcare utilization and cost of pneumococcal disease in the United States. Vaccine 29: 3398–3412 http://dx.doi.org/10.1016/j.vaccine.2011.02.088. [PubMed] · DOI · Paper page
  25. Kramer MR Rudensky B Hadas-Halperin I Isacsohn M Melzer E. 1987. Pneumococcal bacteremia: no change in mortality in 30 years: analysis of 104 cases and review of the literature. Isr J Med Sci 23: 174–180. [PubMed]
  26. Brugger SD Troxler LJ Rüfenacht S Frey PM Morand B Geyer R Mühlemann K Höck S Thormann W Furrer J Christen S Hilty M. 2016. Polysaccharide capsule composition of pneumococcal serotype 19A subtypes is unaltered among subtypes and independent of the nutritional environment. Infect Immun 84: 3152–3160 http://dx.doi.org/10.1128/IAI.00474-16. [PubMed] · doi:10.1128/iai.00474-16
  27. Fiore AE Levine OS Elliott JA Facklam RR Butler JC. 1999. Effectiveness of pneumococcal polysaccharide vaccine for preschool-age children with chronic disease. Emerg Infect Dis 5: 828–831 http://dx.doi.org/10.3201/eid0506.990616. [PubMed] · DOI
  28. Crook DW Brueggemann AB Sleeman KL Peto TEA. 2004. Pneumococcal carriage p 136–147. In Tuomanen EI Mitchell TJ Morrison DA Spratt BG (ed) The Pneumococcus . ASM Press Washington D.C. · DOI
  29. Rodenburg GD de Greeff SC Jansen AG de Melker HE Schouls LM Hak E Spanjaard L Sanders EA van der Ende A. 2010. Effects of pneumococcal conjugate vaccine 2 years after its introduction the Netherlands. Emerg Infect Dis 16: 816–823 http://dx.doi.org/10.3201/eid1605.091223. · DOI · Paper page
  30. Flasche S Van Hoek AJ Sheasby E Waight P Andrews N Sheppard C George R Miller E. 2011. Effect of pneumococcal conjugate vaccination on serotype-specific carriage and invasive disease in England: a cross-sectional study. PLoS Med 8: e1001017 http://dx.doi.org/10.1371/journal.pmed.1001017. [PubMed] · DOI · Paper page
  31. Weiser JN Austrian R Sreenivasan PK Masure HR. 1994. Phase variation in pneumococcal opacity: relationship between colonial morphology and nasopharyngeal colonization. Infect Immun 62: 2582–2589. [PubMed] · DOI · Paper page
  32. Kim JO Weiser JN. 1998. Association of intrastrain phase variation in quantity of capsular polysaccharide and teichoic acid with the virulence of Streptococcus pneumoniae . J Infect Dis 177: 368–377 http://dx.doi.org/10.1086/514205. [PubMed] · DOI · Paper page
  33. Kim JO Romero-Steiner S Sørensen UB Blom J Carvalho M Barnard S Carlone G Weiser JN. 1999. Relationship between cell surface carbohydrates and intrastrain variation on opsonophagocytosis of Streptococcus pneumoniae . Infect Immun 67: 2327–2333. [PubMed] · DOI · Paper page
  34. Rosenow C Ryan P Weiser JN Johnson S Fontan P Ortqvist A Masure HR. 1997. Contribution of novel choline-binding proteins to adherence colonization and immunogenicity of Streptococcus pneumoniae . Mol Microbiol 25: 819–829 http://dx.doi.org/10.1111/j.1365-2958.1997.mmi494.x. [PubMed] · DOI · Paper page
  35. Fernández-Tornero C López R García E Giménez-Gallego G Romero A. 2001. A novel solenoid fold in the cell wall anchoring domain of the pneumococcal virulence factor LytA. Nat Struct Biol 8: 1020–1024 http://dx.doi.org/10.1038/nsb724. [PubMed] · DOI
  36. Vollmer W Tomasz A. 2001. Identification of the teichoic acid phosphorylcholine esterase in Streptococcus pneumoniae . Mol Microbiol 39: 1610–1622 http://dx.doi.org/10.1046/j.1365-2958.2001.02349.x. [PubMed] · DOI
  37. Orihuela CJ Gao G Francis KP Yu J Tuomanen EI. 2004. Tissue-specific contributions of pneumococcal virulence factors to pathogenesis. J Infect Dis 190: 1661–1669 http://dx.doi.org/10.1086/424596. [PubMed] · DOI · Paper page
  38. García P González MP García E López R García JL. 1999. LytB a novel pneumococcal murein hydrolase essential for cell separation. Mol Microbiol 31: 1275–1281 http://dx.doi.org/10.1046/j.1365-2958.1999.01238.x. [PubMed] · DOI
  39. García P Paz González M García E García JL López R. 1999. The molecular characterization of the first autolytic lysozyme of Streptococcus pneumoniae reveals evolutionary mobile domains. Mol Microbiol 33: 128–138 http://dx.doi.org/10.1046/j.1365-2958.1999.01455.x. [PubMed] · DOI
  40. Gosink KK Mann ER Guglielmo C Tuomanen EI Masure HR. 2000. Role of novel choline binding proteins in virulence of Streptococcus pneumoniae . Infect Immun 68: 5690–5695 http://dx.doi.org/10.1128/IAI.68.10.5690-5695.2000. [PubMed] · DOI · Paper page
  41. Weiser JN Bae D Fasching C Scamurra RW Ratner AJ Janoff EN. 2003. Antibody-enhanced pneumococcal adherence requires IgA1 protease. Proc Natl Acad Sci U S A 100: 4215–4220 http://dx.doi.org/10.1073/pnas.0637469100. [PubMed] · DOI · Paper page
  42. Kilian M Mestecky J Russell MW. 1988. Defense mechanisms involving Fc-dependent functions of immunoglobulin A and their subversion by bacterial immunoglobulin A proteases. Microbiol Rev 52: 296–303. [PubMed] · doi:10.1128/mr.52.2.296-303.1988 · Paper page
  43. Sebert ME Palmer LM Rosenberg M Weiser JN. 2002. Microarray-based identification of htrA a Streptococcus pneumoniae gene that is regulated by the CiaRH two-component system and contributes to nasopharyngeal colonization. Infect Immun 70: 4059–4067 http://dx.doi.org/10.1128/IAI.70.8.4059-4067.2002. [PubMed] · DOI
  44. Ibrahim YM Kerr AR McCluskey J Mitchell TJ. 2004. Role of HtrA in the virulence and competence of Streptococcus pneumoniae . Infect Immun 72: 3584–3591 http://dx.doi.org/10.1128/IAI.72.6.3584-3591.2004. [PubMed] · DOI
  45. Orihuela CJ Radin JN Sublett JE Gao G Kaushal D Tuomanen EI. 2004. Microarray analysis of pneumococcal gene expression during invasive disease. Infect Immun 72: 5582–5596 http://dx.doi.org/10.1128/IAI.72.10.5582-5596.2004. [PubMed] · DOI · Paper page
  46. Barocchi MA Ries J Zogaj X Hemsley C Albiger B Kanth A Dahlberg S Fernebro J Moschioni M Masignani V Hultenby K Taddei AR Beiter K Wartha F von Euler A Covacci A Holden DW Normark S Rappuoli R Henriques-Normark B. 2006. A pneumococcal pilus influences virulence and host inflammatory responses. Proc Natl Acad Sci U S A 103: 2857–2862 http://dx.doi.org/10.1073/pnas.0511017103. [PubMed] · DOI · Paper page
  47. LeMieux J Hava DL Basset A Camilli A. 2006. RrgA and RrgB are components of a multisubunit pilus encoded by the Streptococcus pneumoniae rlrA pathogenicity islet. Infect Immun 74: 2453–2456 http://dx.doi.org/10.1128/IAI.74.4.2453-2456.2006. [PubMed] · DOI
  48. Sjöström K Blomberg C Fernebro J Dagerhamn J Morfeldt E Barocchi MA Browall S Moschioni M Andersson M Henriques F Albiger B Rappuoli R Normark S Henriques-Normark B. 2007. Clonal success of piliated penicillin nonsusceptible pneumococci. Proc Natl Acad Sci U S A 104: 12907–12912 http://dx.doi.org/10.1073/pnas.0705589104. [PubMed] · DOI
  49. Moschioni M Donati C Muzzi A Masignani V Censini S Hanage WP Bishop CJ Reis JN Normark S Henriques-Normark B Covacci A Rappuoli R Barocchi MA. 2008. Streptococcus pneumoniae contains 3 rlrA pilus variants that are clonally related. J Infect Dis 197: 888–896 http://dx.doi.org/10.1086/528375. [PubMed] · doi:10.1086/528375
  50. Pancotto L De Angelis G Bizzarri E Barocchi MA Del Giudice G Moschioni M Ruggiero P. 2013. Expression of the Streptococcus pneumoniae pilus-1 undergoes on and off switching during colonization in mice. Sci Rep 3: 2040 http://dx.doi.org/10.1038/srep02040. · doi:10.1038/srep02040
  51. Park IH Kim KH Andrade AL Briles DE McDaniel LS Nahm MH. 2012. Nontypeable pneumococci can be divided into multiple cps types including one type expressing the novel gene pspK . MBio 3: 3 http://dx.doi.org/10.1128/mBio.00035-12. · DOI
  52. Keller LE Jones CV Thornton JA Sanders ME Swiatlo E Nahm MH Park IH McDaniel LS. 2013. PspK of Streptococcus pneumoniae increases adherence to epithelial cells and enhances nasopharyngeal colonization. Infect Immun 81: 173–181 http://dx.doi.org/10.1128/IAI.00755-12. · DOI
  53. Hermans PW Adrian PV Albert C Estevão S Hoogenboezem T Luijendijk IH Kamphausen T Hammerschmidt S. 2006. The streptococcal lipoprotein rotamase A (SlrA) is a functional peptidyl-prolyl isomerase involved in pneumococcal colonization. J Biol Chem 281: 968–976 http://dx.doi.org/10.1074/jbc.M510014200. · DOI
  54. Cron LE Bootsma HJ Noske N Burghout P Hammerschmidt S Hermans PW. 2009. Surface-associated lipoprotein PpmA of Streptococcus pneumoniae is involved in colonization in a strain-specific manner. Microbiology 155: 2401–2410 http://dx.doi.org/10.1099/mic.0.026765-0. · DOI
  55. Marks LR Reddinger RM Hakansson AP. 2012. High levels of genetic recombination during nasopharyngeal carriage and biofilm formation in Streptococcus pneumoniae . MBio 3: e00200-12 http://dx.doi.org/10.1128/mBio.00200-12. · DOI · Paper page
  56. Chao Y Marks LR Pettigrew MM Hakansson AP. 2015. Streptococcus pneumoniae biofilm formation and dispersion during colonization and disease. Front Cell Infect Microbiol 4: 194 http://dx.doi.org/10.3389/fcimb.2014.00194. · DOI · Paper page
  57. Pettigrew MM Marks LR Kong Y Gent JF Roche-Hakansson H Hakansson AP. 2014. Dynamic changes in the Streptococcus pneumoniae transcriptome during transition from biofilm formation to invasive disease upon influenza A virus infection. Infect Immun 82: 4607–4619 http://dx.doi.org/10.1128/IAI.02225-14. · DOI · Paper page
  58. Teele DW Klein JO Rosner B. 1989. Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective cohort study. J Infect Dis 160: 83–94 http://dx.doi.org/10.1093/infdis/160.1.83. · DOI · Paper page
  59. Block SL. 1997. Causative pathogens antibiotic resistance and therapeutic considerations in acute otitis media. Pediatr Infect Dis J 16: 449–456 http://dx.doi.org/10.1097/00006454-199704000-00029. · doi:10.1097/00006454-199704000-00029
  60. Sierra A Lopez P Zapata MA Vanegas B Castrejon MM Deantonio R Hausdorff WP Colindres RE. 2011. Non-typeable Haemophilus influenzae and Streptococcus pneumoniae as primary causes of acute otitis media in Colombian children: a prospective study. BMC Infect Dis 11: 4 http://dx.doi.org/10.1186/1471-2334-11-4. · doi:10.1186/1471-2334-11-4
  61. Rosenblut A Napolitano C Pereira A Moreno C Kolhe D Lepetic A Ortega-Barria E. 2017. Etiology of acute otitis media and serotype distribution of Streptococcus pneumoniae and Haemophilus influenzae in Chilean children <5 years of age. Medicine (Baltimore) 96: e5974 http://dx.doi.org/10.1097/MD.0000000000005974. · doi:10.1097/md.0000000000005974
  62. Pettigrew MM Gent JF Pyles RB Miller AL Nokso-Koivisto J Chonmaitree T. 2011. Viral-bacterial interactions and risk of acute otitis media complicating upper respiratory tract infection. J Clin Microbiol 49: 3750–3755 http://dx.doi.org/10.1128/JCM.01186-11. · DOI · Paper page
  63. Stahl WL O’Toole RD. 1972. Pneumococcal neuraminidase: purification and properties. Biochim Biophys Acta 268: 480–487 http://dx.doi.org/10.1016/0005-2744(72)90343-9. · doi:10.1016/0005-2744(72)90343-9
  64. Berry AM Lock RA Paton JC. 1996. Cloning and characterization of nanB a second Streptococcus pneumoniae neuraminidase gene and purification of the NanB enzyme from recombinant Escherichia coli . J Bacteriol 178: 4854–4860 http://dx.doi.org/10.1128/jb.178.16.4854-4860.1996. [PubMed] · DOI
  65. Tong HH Blue LE James MA DeMaria TF. 2000. Evaluation of the virulence of a Streptococcus pneumoniae neuraminidase-deficient mutant in nasopharyngeal colonization and development of otitis media in the chinchilla model. Infect Immun 68: 921–924 http://dx.doi.org/10.1128/IAI.68.2.921-924.2000. [PubMed] · DOI · Paper page
  66. Tong HH Grants I Liu X DeMaria TF. 2002. Comparison of alteration of cell surface carbohydrates of the chinchilla tubotympanum and colonial opacity phenotype of Streptococcus pneumoniae during experimental pneumococcal otitis media with or without an antecedent influenza A virus infection. Infect Immun 70: 4292–4301 http://dx.doi.org/10.1128/IAI.70.8.4292-4301.2002. [PubMed] · DOI
  67. Tuomanen EI. 2000. Pathogenesis of pneumococcal inflammation: otitis media. Vaccine 19 (Suppl 1) : S38–S40 http://dx.doi.org/10.1016/S0264-410X(00)00276-0. · DOI
  68. Winter AJ Comis SD Osborne MP Tarlow MJ Stephen J Andrew PW Hill J Mitchell TJ. 1997. A role for pneumolysin but not neuraminidase in the hearing loss and cochlear damage induced by experimental pneumococcal meningitis in guinea pigs. Infect Immun 65: 4411–4418. [PubMed] · DOI
  69. Comis SD Osborne MP Stephen J Tarlow MJ Hayward TL Mitchell TJ Andrew PW Boulnois GJ. 1993. Cytotoxic effects on hair cells of guinea pig cochlea produced by pneumolysin the thiol activated toxin of Streptococcus pneumoniae . Acta Otolaryngol 113: 152–159 http://dx.doi.org/10.3109/00016489309135784. [PubMed] · DOI
  70. Zhang JR Mostov KE Lamm ME Nanno M Shimida S Ohwaki M Tuomanen E. 2000. The polymeric immunoglobulin receptor translocates pneumococci across human nasopharyngeal epithelial cells. Cell 102: 827–837 http://dx.doi.org/10.1016/S0092-8674(00)00071-4. · DOI · Paper page
  71. Kaetzel CS. 2001. Polymeric Ig receptor: defender of the fort or Trojan horse? Curr Biol 11: R35–R38 http://dx.doi.org/10.1016/S0960-9822(00)00041-5. · DOI
  72. Lu L Lamm ME Li H Corthesy B Zhang JR. 2003. The human polymeric immunoglobulin receptor binds to Streptococcus pneumoniae via domains 3 and 4. J Biol Chem 278: 48178–48187 http://dx.doi.org/10.1074/jbc.M306906200. [PubMed] · DOI
  73. Luton F Vergés M Vaerman JP Sudol M Mostov KE. 1999. The SRC family protein tyrosine kinase p62yes controls polymeric IgA transcytosis in vivo . Mol Cell 4: 627–632 http://dx.doi.org/10.1016/S1097-2765(00)80213-0. · DOI
  74. Tong HH McIver MA Fisher LM DeMaria TF. 1999. Effect of lacto-N-neotetraose asialoganglioside-GM1 and neuraminidase on adherence of otitis media-associated serotypes of Streptococcus pneumoniae to chinchilla tracheal epithelium. Microb Pathog 26: 111–119 http://dx.doi.org/10.1006/mpat.1998.0257. [PubMed] · DOI
  75. Kietzman CC Gao G Mann B Myers L Tuomanen EI. 2016. Dynamic capsule restructuring by the main pneumococcal autolysin LytA in response to the epithelium. Nat Commun 7: 10859 http://dx.doi.org/10.1038/ncomms10859. [PubMed] · doi:10.1038/ncomms10859
  76. Krivan HC Roberts DD Ginsburg V. 1988. Many pulmonary pathogenic bacteria bind specifically to the carbohydrate sequence GalNAc beta 1-4Gal found in some glycolipids. Proc Natl Acad Sci U S A 85: 6157–6161 http://dx.doi.org/10.1073/pnas.85.16.6157. [PubMed] · DOI · Paper page
  77. Howie AJ Brown G. 1985. Effect of neuraminidase on the expression of the 3-fucosyl- N -acetyllactosamine antigen in human tissues. J Clin Pathol 38: 409–416 http://dx.doi.org/10.1136/jcp.38.4.409. [PubMed] · DOI
  78. Kahya HF Andrew PW Yesilkaya H. 2017. Deacetylation of sialic acid by esterases potentiates pneumococcal neuraminidase activity for mucin utilization colonization and virulence. PLoS Pathog 13: e1006263 http://dx.doi.org/10.1371/journal.ppat.1006263. · DOI
  79. Peltola VT McCullers JA. 2004. Respiratory viruses predisposing to bacterial infections: role of neuraminidase. Pediatr Infect Dis J 23 (Suppl) : S87–S97 http://dx.doi.org/10.1097/01.inf.0000108197.81270.35. [PubMed] · DOI · Paper page
  80. McCullers JA Bartmess KC. 2003. Role of neuraminidase in lethal synergism between influenza virus and Streptococcus pneumoniae . J Infect Dis 187: 1000–1009 http://dx.doi.org/10.1086/368163. [PubMed] · DOI · Paper page
  81. McCullers JA. 2004. Effect of antiviral treatment on the outcome of secondary bacterial pneumonia after influenza. J Infect Dis 190: 519–526 http://dx.doi.org/10.1086/421525. [PubMed] · DOI · Paper page
  82. Agarwal V Kuchipudi A Fulde M Riesbeck K Bergmann S Blom AM. 2013. Streptococcus pneumoniae endopeptidase O (PepO) is a multifunctional plasminogen- and fibronectin-binding protein facilitating evasion of innate immunity and invasion of host cells. J Biol Chem 288: 6849–6863 http://dx.doi.org/10.1074/jbc.M112.405530. [PubMed] · DOI
  83. Löfling J Vimberg V Battig P Henriques-Normark B. 2011. Cellular interactions by LPxTG-anchored pneumococcal adhesins and their streptococcal homologues. Cell Microbiol 13: 186–197 http://dx.doi.org/10.1111/j.1462-5822.2010.01560.x. [PubMed] · DOI
  84. Jensch I Gámez G Rothe M Ebert S Fulde M Somplatzki D Bergmann S Petruschka L Rohde M Nau R Hammerschmidt S. 2010. PavB is a surface-exposed adhesin of Streptococcus pneumoniae contributing to nasopharyngeal colonization and airways infections. Mol Microbiol 77: 22–43 http://dx.doi.org/10.1111/j.1365-2958.2010.07189.x. [PubMed] · DOI · Paper page
  85. Pracht D Elm C Gerber J Bergmann S Rohde M Seiler M Kim KS Jenkinson HF Nau R Hammerschmidt S. 2005. PavA of Streptococcus pneumoniae modulates adherence invasion and meningeal inflammation. Infect Immun 73: 2680–2689 http://dx.doi.org/10.1128/IAI.73.5.2680-2689.2005. [PubMed] · DOI · Paper page
  86. Tuomanen E. 2004. Attachment and invasion of the respiratory tract p 221–237. In Tuomanen E Mitchell T Morrison DA Spratt BG (ed) The Pneumococcus . ASM Press Washington DC. · DOI
  87. Berry AM Paton JC. 2000. Additive attenuation of virulence of Streptococcus pneumoniae by mutation of the genes encoding pneumolysin and other putative pneumococcal virulence proteins. Infect Immun 68: 133–140 http://dx.doi.org/10.1128/IAI.68.1.133-140.2000. [PubMed] · DOI · Paper page
  88. Feldman C Anderson R Cockeran R Mitchell T Cole P Wilson R. 2002. The effects of pneumolysin and hydrogen peroxide alone and in combination on human ciliated epithelium in vitro . Respir Med 96: 580–585 http://dx.doi.org/10.1053/rmed.2002.1316. [PubMed] · DOI
  89. Canvin JR Marvin AP Sivakumaran M Paton JC Boulnois GJ Andrew PW Mitchell TJ. 1995. The role of pneumolysin and autolysin in the pathology of pneumonia and septicemia in mice infected with a type 2 pneumococcus. J Infect Dis 172: 119–123 http://dx.doi.org/10.1093/infdis/172.1.119. [PubMed] · DOI · Paper page
  90. Tuomanen E Rich R Zak O. 1987. Induction of pulmonary inflammation by components of the pneumococcal cell surface. Am Rev Respir Dis 135: 869–874 http://dx.doi.org/10.1164/arrd.1987.135.4.869. [PubMed] · DOI
  91. Rubins JB Charboneau D Paton JC Mitchell TJ Andrew PW Janoff EN. 1995. Dual function of pneumolysin in the early pathogenesis of murine pneumococcal pneumonia. J Clin Invest 95: 142–150 http://dx.doi.org/10.1172/JCI117631. [PubMed] · DOI
  92. Spellerberg B Cundell DR Sandros J Pearce BJ Idanpaan-Heikkila I Rosenow C Masure HR. 1996. Pyruvate oxidase as a determinant of virulence in Streptococcus pneumoniae . Mol Microbiol 19: 803–813 http://dx.doi.org/10.1046/j.1365-2958.1996.425954.x. [PubMed] · DOI · Paper page
  93. Berry AM Paton JC Hansman D. 1992. Effect of insertional inactivation of the genes encoding pneumolysin and autolysin on the virulence of Streptococcus pneumoniae type 3. Microb Pathog 12: 87–93 http://dx.doi.org/10.1016/0882-4010(92)90111-Z. · DOI
  94. Cundell DR Gerard NP Gerard C Idanpaan-Heikkila I Tuomanen EI. 1995. Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor. Nature 377: 435–438 http://dx.doi.org/10.1038/377435a0. [PubMed] · DOI · Paper page
  95. Radin JN Orihuela CJ Murti G Guglielmo C Murray PJ Tuomanen E. 2005. B-arrestin 1 participates in platelet-activating factor receptor-mediated endocytosis of Streptococcus pneumoniae . Infect Immu 73: 7827–7835. [PubMed] · DOI
  96. Weiser JN Goldberg JB Pan N Wilson L Virji M. 1998. The phosphorylcholine epitope undergoes phase variation on a 43-kilodalton protein in Pseudomonas aeruginosa and on pili of Neisseria meningitidis and Neisseria gonorrhoeae . Infect Immun 66: 4263–4267. [PubMed] · DOI
  97. Weiser JN Shchepetov M Chong ST. 1997. Decoration of lipopolysaccharide with phosphorylcholine: a phase-variable characteristic of Haemophilus influenzae . Infect Immun 65: 943–950. [PubMed] · DOI · Paper page
  98. Loughran AJ Tuomanen EI. 2016. Blood borne: bacterial components in mother’s blood influence fetal development. Inflamm Cell Signal 3: e1421. [PubMed]
  99. Gould JM Weiser JN. 2001. Expression of C-reactive protein in the human respiratory tract. Infect Immun 69: 1747–1754 http://dx.doi.org/10.1128/IAI.69.3.1747-1754.2001. [PubMed] · DOI · Paper page
  100. Seachrist JL Ferguson SS. 2003. Regulation of G protein-coupled receptor endocytosis and trafficking by Rab GTPases. Life Sci 74: 225–235 http://dx.doi.org/10.1016/j.lfs.2003.09.009. [PubMed] · DOI · Paper page
  101. Orrskog S Rounioja S Spadafina T Gallotta M Norman M Hentrich K Fälker S Ygberg-Eriksson S Hasenberg M Johansson B Uotila LM Gahmberg CG Barocchi M Gunzer M Normark S Henriques-Normark B. 2012. Pilus adhesin RrgA interacts with complement receptor 3 thereby affecting macrophage function and systemic pneumococcal disease. MBio 4: e00535-12 http://dx.doi.org/10.1128/mBio.00535-12. [PubMed] · DOI
  102. Loh LN Gao G Tuomanen EI. 2017. Dissecting bacterial cell wall entry and signaling in eukaryotic cells: an actin-dependent pathway parallels platelet-activating factor receptor-mediated endocytosis. MBio 8: e02030-16 http://dx.doi.org/10.1128/mBio.02030-16. · DOI
  103. Abeyta M Hardy GG Yother J. 2003. Genetic alteration of capsule type but not PspA type affects accessibility of surface-bound complement and surface antigens of Streptococcus pneumoniae . Infect Immun 71: 218–225 http://dx.doi.org/10.1128/IAI.71.1.218-225.2003. · DOI · Paper page
  104. Magee AD Yother J. 2001. Requirement for capsule in colonization by Streptococcus pneumoniae . Infect Immun 69: 3755–3761 http://dx.doi.org/10.1128/IAI.69.6.3755-3761.2001. · DOI · Paper page
  105. Kelly T Dillard JP Yother J. 1994. Effect of genetic switching of capsular type on virulence of Streptococcus pneumoniae . Infect Immun 62: 1813–1819. · doi:10.1128/iai.62.5.1813-1819.1994
  106. Briles DE Crain MJ Gray BM Forman C Yother J. 1992. Strong association between capsular type and virulence for mice among human isolates of Streptococcus pneumoniae . Infect Immun 60: 111–116. · DOI · Paper page
  107. Fine DP. 1975. Pneumococcal type-associated variability in alternate complement pathway activation. Infect Immun 12: 772–778. · DOI
  108. Hostetter MK. 1986. Serotypic variations among virulent pneumococci in deposition and degradation of covalently bound C3b: implications for phagocytosis and antibody production. J Infect Dis 153: 682–693 http://dx.doi.org/10.1093/infdis/153.4.682. · DOI
  109. Ren B Szalai AJ Hollingshead SK Briles DE. 2004. Effects of PspA and antibodies to PspA on activation and deposition of complement on the pneumococcal surface. Infect Immun 72: 114–122 http://dx.doi.org/10.1128/IAI.72.1.114-122.2004. · doi:10.1128/iai.72.1.114-122.2004
  110. Ren B Szalai AJ Thomas O Hollingshead SK Briles DE. 2003. Both family 1 and family 2 PspA proteins can inhibit complement deposition and confer virulence to a capsular serotype 3 strain of Streptococcus pneumoniae . Infect Immun 71: 75–85 http://dx.doi.org/10.1128/IAI.71.1.75-85.2003. · DOI
  111. Tu AH Fulgham RL McCrory MA Briles DE Szalai AJ. 1999. Pneumococcal surface protein A inhibits complement activation by Streptococcus pneumoniae . Infect Immun 67: 4720–4724. · DOI · Paper page
  112. Shaper M Hollingshead SK Benjamin WH Jr Briles DE. 2004. PspA protects Streptococcus pneumoniae from killing by apolactoferrin and antibody to PspA enhances killing of pneumococci by apolactoferrin [corrected]. Infect Immun 72: 5031–5040 http://dx.doi.org/10.1128/IAI.72.9.5031-5040.2004. · DOI · Paper page
  113. Duthy TG Ormsby RJ Giannakis E Ogunniyi AD Stroeher UH Paton JC Gordon DL. 2002. The human complement regulator factor H binds pneumococcal surface protein PspC via short consensus repeats 13 to 15. Infect Immun 70: 5604–5611 http://dx.doi.org/10.1128/IAI.70.10.5604-5611.2002. · DOI
  114. Mohan S Hertweck C Dudda A Hammerschmidt S Skerka C Hallström T Zipfel PF. 2014. Tuf of Streptococcus pneumoniae is a surface displayed human complement regulator binding protein. Mol Immunol 62: 249–264 http://dx.doi.org/10.1016/j.molimm.2014.06.029. · DOI
  115. Dalia AB Standish AJ Weiser JN. 2010. Three surface exoglycosidases from Streptococcus pneumoniae NanA BgaA and StrH promote resistance to opsonophagocytic killing by human neutrophils. Infect Immun 78: 2108–2116 http://dx.doi.org/10.1128/IAI.01125-09. · DOI
  116. Ramirez JA Wiemken TL Peyrani P Arnold FW Kelley R Mattingly WA Nakamatsu R Pena S Guinn BE Furmanek SP Persaud AK Raghuram A Fernandez F Beavin L Bosson R Fernandez-Botran R Cavallazzi R Bordon J Valdivieso C Schulte J Carrico RM University of Louisville Pneumonia Study Group. 2017. Adults hospitalized with pneumonia in the United States: incidence epidemiology and mortality. Clin Infect Dis 65: 1806–1812 http://dx.doi.org/10.1093/cid/cix647. · DOI · Paper page
  117. Brown AO Mann B Gao G Hankins JS Humann J Giardina J Faverio P Restrepo MI Halade GV Mortensen EM Lindsey ML Hanes M Happel KI Nelson S Bagby GJ Lorent JA Cardinal P Granados R Esteban A LeSaux CJ Tuomanen EI Orihuela CJ. 2014. Streptococcus pneumoniae translocates into the myocardium and forms unique microlesions that disrupt cardiac function. PLoS Pathog 10: e1004383 http://dx.doi.org/10.1371/journal.ppat.1004383. · DOI · Paper page
  118. Musher DM Rueda AM Kaka AS Mapara SM. 2007. The association between pneumococcal pneumonia and acute cardiac events. Clin Infect Dis 45: 158–165 http://dx.doi.org/10.1086/518849. · DOI · Paper page
  119. Reyes LF Restrepo MI Hinojosa CA Soni NJ Anzueto A Babu BL Gonzalez-Juarbe N Rodriguez AH Jimenez A Chalmers JD Aliberti S Sibila O Winter VT Coalson JJ Giavedoni LD Dela Cruz CS Waterer GW Witzenrath M Suttorp N Dube PH Orihuela CJ. 2017. Severe pneumococcal pneumonia causes acute cardiac toxicity and subsequent cardiac remodeling. Am J Respir Crit Care Med 196: 609–620 http://dx.doi.org/10.1164/rccm.201701-0104OC. · DOI
  120. Fillon S Soulis K Rajasekaran S Benedict-Hamilton H Radin JN Orihuela CJ El Kasmi KC Murti G Kaushal D Gaber MW Weber JR Murray PJ Tuomanen EI. 2006. Platelet-activating factor receptor and innate immunity: uptake of Gram-positive bacterial cell wall into host cells and cell-specific pathophysiology. J Immunol 177: 6182–6191 http://dx.doi.org/10.4049/jimmunol.177.9.6182. · DOI
  121. Alhamdi Y Neill DR Abrams ST Malak HA Yahya R Barrett-Jolley R Wang G Kadioglu A Toh CH. 2015. Circulating pneumolysin is a potent inducer of cardiac injury during pneumococcal infection. PLoS Pathog 11: e1004836 http://dx.doi.org/10.1371/journal.ppat.1004836. · DOI
  122. Brissac T Shenoy AT Patterson LA Orihuela CJ Pirofski L. 2017. Cell invasion and pyruvate oxidase derived H 2 O 2 are critical for Streptococcus pneumoniae mediated cardiomyocyte killing. Infect Immun 86: IAI.00569-17 http://dx.doi.org/10.1128/IAI.00569-17. · DOI
  123. Thigpen MC Whitney CG Messonnier NE Zell ER Lynfield R Hadler JL Harrison LH Farley MM Reingold A Bennett NM Craig AS Schaffner W Thomas A Lewis MM Scallan E Schuchat A Emerging Infections Programs Network. 2011. Bacterial meningitis in the United States 1998-2007. N Engl J Med 364: 2016–2025 http://dx.doi.org/10.1056/NEJMoa1005384. · DOI · Paper page
  124. Hameed N Tunkel AR. 2010. Treatment of drug-resistant pneumococcal meningitis. Curr Infect Dis Rep 12: 274–281 http://dx.doi.org/10.1007/s11908-010-0110-7. · DOI
  125. de Gans J van de Beek D European Dexamethasone in Adulthood Bacterial Meningitis Study Investigators. 2002. Dexamethasone in adults with bacterial meningitis. N Engl J Med 347: 1549–1556 http://dx.doi.org/10.1056/NEJMoa021334. · DOI · Paper page
  126. Hoffmann O Mahrhofer C Rueter N Freyer D Bert B Fink H Weber JR. 2007. Pneumococcal cell wall-induced meningitis impairs adult hippocampal neurogenesis. Infect Immun 75: 4289–4297 http://dx.doi.org/10.1128/IAI.01679-06. · DOI
  127. Gerber J Pohl K Sander V Bunkowski S Nau R. 2003. Rifampin followed by ceftriaxone for experimental meningitis decreases lipoteichoic acid concentrations in cerebrospinal fluid and reduces neuronal damage in comparison to ceftriaxone alone. Antimicrob Agents Chemother 47: 1313–1317 http://dx.doi.org/10.1128/AAC.47.4.1313-1317.2003. · DOI
  128. Free SL Li LM Fish DR Shorvon SD Stevens JM. 1996. Bilateral hippocampal volume loss in patients with a history of encephalitis or meningitis. Epilepsia 37: 400–405 http://dx.doi.org/10.1111/j.1528-1157.1996.tb00578.x. · DOI
  129. Braun JS Novak R Herzog KH Bodner SM Cleveland JL Tuomanen EI. 1999. Neuroprotection by a caspase inhibitor in acute bacterial meningitis. Nat Med 5: 298–302 http://dx.doi.org/10.1038/6514. · DOI · Paper page
  130. Hanisch UK Prinz M Angstwurm K Häusler KG Kann O Kettenmann H Weber JR. 2001. The protein tyrosine kinase inhibitor AG126 prevents the massive microglial cytokine induction by pneumococcal cell walls. Eur J Immunol 31: 2104–2115 http://dx.doi.org/10.1002/1521-4141(200107)31:7<2104::AID-IMMU2104>3.0.CO;2-3. · DOI
  131. Freyer D Manz R Ziegenhorn A Weih M Angstwurm K Döcke WD Meisel A Schumann RR Schönfelder G Dirnagl U Weber JR. 1999. Cerebral endothelial cells release TNF-alpha after stimulation with cell walls of Streptococcus pneumoniae and regulate inducible nitric oxide synthase and ICAM-1 expression via autocrine loops. J Immunol 163: 4308–4314. · DOI
  132. Meli DN Christen S Leib SL. 2003. Matrix metalloproteinase-9 in pneumococcal meningitis: activation via an oxidative pathway. J Infect Dis 187: 1411–1415 http://dx.doi.org/10.1086/374644. · DOI
  133. Kastenbauer S Koedel U Pfister HW. 1999. Role of peroxynitrite as a mediator of pathophysiological alterations in experimental pneumococcal meningitis. J Infect Dis 180: 1164–1170 http://dx.doi.org/10.1086/315048. · DOI
  134. Weber JR Angstwurm K Bürger W Einhäupl KM Dirnagl U. 1995. Anti ICAM-1 (CD 54) monoclonal antibody reduces inflammatory changes in experimental bacterial meningitis. J Neuroimmunol 63: 63–68 http://dx.doi.org/10.1016/0165-5728(95)00131-X. · DOI
  135. Tuomanen EI Saukkonen K Sande S Cioffe C Wright SD. 1989. Reduction of inflammation tissue damage and mortality in bacterial meningitis in rabbits treated with monoclonal antibodies against adhesion-promoting receptors of leukocytes. J Exp Med 170: 959–969 http://dx.doi.org/10.1084/jem.170.3.959. · DOI · Paper page
  136. Braun JS Sublett JE Freyer D Mitchell TJ Cleveland JL Tuomanen EI Weber JR. 2002. Pneumococcal pneumolysin and H(2)O(2) mediate brain cell apoptosis during meningitis. J Clin Invest 109: 19–27 http://dx.doi.org/10.1172/JCI12035. · DOI · Paper page
  137. Orihuela CJ Fillon S Smith-Sielicki SH El Kasmi KC Gao G Soulis K Patil A Murray PJ Tuomanen EI. 2006. Cell wall-mediated neuronal damage in early sepsis. Infect Immun 74: 3783–3789 http://dx.doi.org/10.1128/IAI.00022-06. · DOI
  138. Ring A Weiser JN Tuomanen EI. 1998. Pneumococcal trafficking across the blood-brain barrier. Molecular analysis of a novel bidirectional pathway. J Clin Invest 102: 347–360 http://dx.doi.org/10.1172/JCI2406. · DOI · Paper page
  139. Banerjee A Van Sorge NM Sheen TR Uchiyama S Mitchell TJ Doran KS. 2010. Activation of brain endothelium by pneumococcal neuraminidase NanA promotes bacterial internalization. Cell Microbiol 12: 1576–1588 http://dx.doi.org/10.1111/j.1462-5822.2010.01490.x. · DOI
  140. Uchiyama S Carlin AF Khosravi A Weiman S Banerjee A Quach D Hightower G Mitchell TJ Doran KS Nizet V. 2009. The surface-anchored NanA protein promotes pneumococcal brain endothelial cell invasion. J Exp Med 206: 1845–1852 http://dx.doi.org/10.1084/jem.20090386. [PubMed] · DOI · Paper page
  141. Tomasz A Saukkonen K. 1989. The nature of cell wall-derived inflammatory components of pneumococci. Pediatr Infect Dis J 8: 902–903 http://dx.doi.org/10.1097/00006454-198912000-00034. [PubMed] · doi:10.1097/00006454-198912000-00034
  142. Tuomanen EI Austrian R Masure HR. 1995. Pathogenesis of pneumococcal infection. N Engl J Med 332: 1280–1284 http://dx.doi.org/10.1056/NEJM199505113321907. [PubMed] · DOI · Paper page
  143. Moreillon P Majcherczyk PA. 2003. Proinflammatory activity of cell-wall constituents from Gram-positive bacteria. Scand J Infect Dis 35: 632–641 http://dx.doi.org/10.1080/00365540310016259. [PubMed] · DOI
  144. Tuomanen E Tomasz A Hengstler B Zak O. 1985. The relative role of bacterial cell wall and capsule in the induction of inflammation in pneumococcal meningitis. J Infect Dis 151: 535–540 http://dx.doi.org/10.1093/infdis/151.3.535. [PubMed] · DOI · Paper page
  145. Winkelstein JA Tomasz A. 1978. Activation of the alternative complement pathway by pneumococcal cell wall teichoic acid. J Immunol 120: 174–178. [PubMed] · DOI
  146. Weber JR Freyer D Alexander C Schröder NW Reiss A Küster C Pfeil D Tuomanen EI Schumann RR. 2003. Recognition of pneumococcal peptidoglycan: an expanded pivotal role for LPS binding protein. Immunity 19: 269–279 http://dx.doi.org/10.1016/S1074-7613(03)00205-X. · DOI
  147. Ozinsky A Underhill DM Fontenot JD Hajjar AM Smith KD Wilson CB Schroeder L Aderem A. 2000. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between Toll-like receptors. Proc Natl Acad Sci U S A 97: 13766–13771 http://dx.doi.org/10.1073/pnas.250476497. [PubMed] · DOI · Paper page
  148. Spellerberg B Rosenow C Sha W Tuomanen EI. 1996. Pneumococcal cell wall activates NF-kappa B in human monocytes: aspects distinct from endotoxin. Microb Pathog 20: 309–317 http://dx.doi.org/10.1006/mpat.1996.0029. [PubMed] · doi:10.1006/mpat.1996.0029
  149. Girardin SE Boneca IG Carneiro LA Antignac A Jéhanno M Viala J Tedin K Taha MK Labigne A Zähringer U Coyle AJ DiStefano PS Bertin J Sansonetti PJ Philpott DJ. 2003. Nod1 detects a unique muropeptide from Gram-negative bacterial peptidoglycan. Science 300: 1584–1587 http://dx.doi.org/10.1126/science.1084677. [PubMed] · DOI · Paper page
  150. Watanabe T Kitani A Murray PJ Strober W. 2004. NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses. Nat Immunol 5: 800–808 http://dx.doi.org/10.1038/ni1092. [PubMed] · DOI · Paper page
  151. Hostetter MK Thomas ML Rosen FS Tack BF. 1982. Binding of C3b proceeds by a transesterification reaction at the thiolester site. Nature 298: 72–75 http://dx.doi.org/10.1038/298072b0. [PubMed] · DOI
  152. Hummell DS Berninger RW Tomasz A Winkelstein JA. 1981. The fixation of C3b to pneumococcal cell wall polymers as a result of activation of the alternative complement pathway. J Immunol 127: 1287–1289. [PubMed] · doi:10.4049/jimmunol.127.4.1287
  153. Weis WI Drickamer K Hendrickson WA. 1992. Structure of a C-type mannose-binding protein complexed with an oligosaccharide. Nature 360: 127–134 http://dx.doi.org/10.1038/360127a0. [PubMed] · DOI · Paper page
  154. Roy S Knox K Segal S Griffiths D Moore CE Welsh KI Smarason A Day NP McPheat WL Crook DW Hill AV Oxford Pneumoccocal Surveillance Group. 2002. MBL genotype and risk of invasive pneumococcal disease: a case-control study. Lancet 359: 1569–1573 http://dx.doi.org/10.1016/S0140-6736(02)08516-1. · DOI · Paper page
  155. Holzer TJ Edwards KM Gewurz H Mold C. 1984. Binding of C-reactive protein to the pneumococcal capsule or cell wall results in differential localization of C3 and stimulation of phagocytosis. J Immunol 133: 1424–1430. [PubMed] · doi:10.4049/jimmunol.133.3.1424
  156. Agarwal V Sroka M Fulde M Bergmann S Riesbeck K Blom AM. 2014. Binding of Streptococcus pneumoniae endopeptidase O (PepO) to complement component C1q modulates the complement attack and promotes host cell adherence. J Biol Chem 289: 15833–15844 http://dx.doi.org/10.1074/jbc.M113.530212. [PubMed] · DOI
  157. Zou J Zhou L Hu C Jing P Guo X Liu S Lei Y Yang S Deng J Zhang H. 2017. IL-8 and IP-10 expression from human bronchial epithelial cells BEAS-2B are promoted by Streptococcus pneumoniae endopeptidase O (PepO). BMC Microbiol 17: 187 http://dx.doi.org/10.1186/s12866-017-1081-8. [PubMed] · DOI
  158. Nau R Eiffert H. 2002. Modulation of release of proinflammatory bacterial compounds by antibacterials: potential impact on course of inflammation and outcome in sepsis and meningitis. Clin Microbiol Rev 15: 95–110 http://dx.doi.org/10.1128/CMR.15.1.95-110.2002. [PubMed] · DOI · Paper page
  159. Mitchell TJ Andrew PW Saunders FK Smith AN Boulnois GJ. 1991. Complement activation and antibody binding by pneumolysin via a region of the toxin homologous to a human acute-phase protein. Mol Microbiol 5: 1883–1888 http://dx.doi.org/10.1111/j.1365-2958.1991.tb00812.x. [PubMed] · DOI
  160. Alcantara RB Preheim LC Gentry-Nielsen MJ. 2001. Pneumolysin-induced complement depletion during experimental pneumococcal bacteremia. Infect Immun 69: 3569–3575 http://dx.doi.org/10.1128/IAI.69.6.3569-3575.2001. [PubMed] · DOI
  161. Alcantara RB Preheim LC Gentry MJ. 1999. Role of pneumolysin’s complement-activating activity during pneumococcal bacteremia in cirrhotic rats. Infect Immun 67: 2862–2866. [PubMed] · DOI
  162. Tomasz A Albino A Zanati E. 1970. Multiple antibiotic resistance in a bacterium with suppressed autolytic system. Nature 227: 138–140 http://dx.doi.org/10.1038/227138a0. [PubMed] · DOI · Paper page
  163. Jedrzejas MJ. 2001. Pneumococcal virulence factors: structure and function. Microbiol Mol Biol Rev 65: 187–207 http://dx.doi.org/10.1128/MMBR.65.2.187-207.2001. [PubMed] · DOI · Paper page
  164. Blom AM Bergmann S Fulde M Riesbeck K Agarwal V. 2014. Streptococcus pneumoniae phosphoglycerate kinase is a novel complement inhibitor affecting the membrane attack complex formation. J Biol Chem 289: 32499–32511 http://dx.doi.org/10.1074/jbc.M114.610212. [PubMed] · DOI
  165. Stringaris AK Geisenhainer J Bergmann F Balshüsemann C Lee U Zysk G Mitchell TJ Keller BU Kuhnt U Gerber J Spreer A Bähr M Michel U Nau R. 2002. Neurotoxicity of pneumolysin a major pneumococcal virulence factor involves calcium influx and depends on activation of p38 mitogen-activated protein kinase. Neurobiol Dis 11: 355–368 http://dx.doi.org/10.1006/nbdi.2002.0561. [PubMed] · DOI
  166. Berry AM Lock RA Hansman D Paton JC. 1989. Contribution of autolysin to virulence of Streptococcus pneumoniae . Infect Immun 57: 2324–2330. [PubMed] · DOI · Paper page
  167. Balachandran P Hollingshead SK Paton JC Briles DE. 2001. The autolytic enzyme LytA of Streptococcus pneumoniae is not responsible for releasing pneumolysin. J Bacteriol 183: 3108–3116 http://dx.doi.org/10.1128/JB.183.10.3108-3116.2001. [PubMed] · DOI
  168. Price KE Greene NG Camilli A. 2012. Export requirements of pneumolysin in Streptococcus pneumoniae . J Bacteriol 194: 3651–3660 http://dx.doi.org/10.1128/JB.00114-12. [PubMed] · DOI
  169. González-Juarbe N Bradley KM Shenoy AT Gilley RP Reyes LF Hinojosa CA Restrepo MI Dube PH Bergman MA Orihuela CJ. 2017. Pore-forming toxin-mediated ion dysregulation leads to death receptor-independent necroptosis of lung epithelial cells during bacterial pneumonia. Cell Death Differ 24: 917–928 http://dx.doi.org/10.1038/cdd.2017.49. [PubMed] · DOI
  170. González-Juarbe N Gilley RP Hinojosa CA Bradley KM Kamei A Gao G Dube PH Bergman MA Orihuela CJ. 2015. Pore-forming toxins induce macrophage necroptosis during acute bacterial pneumonia. PLoS Pathog 11: e1005337 http://dx.doi.org/10.1371/journal.ppat.1005337. [PubMed] · DOI · Paper page
  171. Gilbert RJ Jiménez JL Chen S Tickle IJ Rossjohn J Parker M Andrew PW Saibil HR. 1999. Two structural transitions in membrane pore formation by pneumolysin the pore-forming toxin of Streptococcus pneumoniae . Cell 97: 647–655 http://dx.doi.org/10.1016/S0092-8674(00)80775-8. · DOI · Paper page
  172. Steinfort C Wilson R Mitchell T Feldman C Rutman A Todd H Sykes D Walker J Saunders K Andrew PW. 1989. Effect of Streptococcus pneumoniae on human respiratory epithelium in vitro . Infect Immun 57: 2006–2013. [PubMed] · DOI
  173. Rayner CF Jackson AD Rutman A Dewar A Mitchell TJ Andrew PW Cole PJ Wilson R. 1995. Interaction of pneumolysin-sufficient and -deficient isogenic variants of Streptococcus pneumoniae with human respiratory mucosa. Infect Immun 63: 442–447. [PubMed] · DOI
  174. Paton JC Ferrante A. 1983. Inhibition of human polymorphonuclear leukocyte respiratory burst bactericidal activity and migration by pneumolysin. Infect Immun 41: 1212–1216. [PubMed] · doi:10.1128/iai.41.3.1212-1216.1983
  175. Cockeran R Theron AJ Feldman C Mitchel TJ Anderson R. 2004. Pneumolysin potentiates oxidative inactivation of alpha-1-proteinase inhibitor by activated human neutrophils. Respir Med 98: 865–871 http://dx.doi.org/10.1016/j.rmed.2004.02.014. [PubMed] · doi:10.1016/j.rmed.2004.02.014
  176. Maus UA Srivastava M Paton JC Mack M Everhart MB Blackwell TS Christman JW Schlöndorff D Seeger W Lohmeyer J. 2004. Pneumolysin-induced lung injury is independent of leukocyte trafficking into the alveolar space. J Immunol 173: 1307–1312 http://dx.doi.org/10.4049/jimmunol.173.2.1307. [PubMed] · DOI
  177. Hirst RA Rutman A Sikand K Andrew PW Mitchell TJ O’Callaghan C. 2000. Effect of pneumolysin on rat brain ciliary function: comparison of brain slices with cultured ependymal cells. Pediatr Res 47: 381–384 http://dx.doi.org/10.1203/00006450-200003000-00016. [PubMed] · DOI
  178. Hirst RA Sikand KS Rutman A Mitchell TJ Andrew PW O’Callaghan C. 2000. Relative roles of pneumolysin and hydrogen peroxide from Streptococcus pneumoniae in inhibition of ependymal ciliary beat frequency. Infect Immun 68: 1557–1562 http://dx.doi.org/10.1128/IAI.68.3.1557-1562.2000. [PubMed] · DOI
  179. Rossjohn J Feil SC McKinstry WJ Tweten RK Parker MW. 1997. Structure of a cholesterol-binding thiol-activated cytolysin and a model of its membrane form. Cell 89: 685–692 http://dx.doi.org/10.1016/S0092-8674(00)80251-2. · DOI · Paper page
  180. Saunders FK Mitchell TJ Walker JA Andrew PW Boulnois GJ. 1989. Pneumolysin the thiol-activated toxin of Streptococcus pneumoniae does not require a thiol group for in vitro activity. Infect Immun 57: 2547–2552. [PubMed] · doi:10.1128/iai.57.8.2547-2552.1989

Cited by

See all 175

Metadata

Authors
Loughran, A. J., Orihuela, C. J., & Tuomanen, E. I.
Venue
Microbiology Spectrum
Published
2019-04-12
Volume
7
Issue
2
ISSN
2165-0497 (ISSN-L)
OpenAlex
W1594640193
Cited by
175
References
9
FWCI
9.11
Type
journal article
Language
en
Open access
green
Licence
journals.asm.org/non-commercial-tdm-license (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.